Suchergebnisse - "Nishio, Makoto"

PubPharm (407)

1

Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers

enthalten in: Thoracic cancer | 2024

von Akita, T. | Ariyasu, R. | Kakuto, S. | +9

2

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

3

HERTHENA-Lung02 : phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI

enthalten in: Future oncology (London, England) | 2024

von Mok, T. | Jänne, P. | Nishio, M. | +10

4

KEYNOTE-434 part B : A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer

enthalten in: Investigational new drugs | 2024

von Yamamoto, N. | Satouchi, M. | Doi, T. | +10

5

Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced NSCLC-A Brief Report From the CROWN Study

enthalten in: JTO clinical and research reports | 2024

von Teraoka, S. | Hayashi, H. | Goto, Y. | +8

6

A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer

enthalten in: NPJ precision oncology | 2024

von Suzuki, M. | Uchibori, K. | Oh-Hara, T. | +13

7

Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer

enthalten in: Investigational new drugs | 2024

von Nogami, N. | Tokito, T. | Zenke, Y. | +7

8

Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma

enthalten in: Diagnostic pathology | 2024

von Ninomiya, H. | Sato, Y. | Inamura, K. | +6

9

Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion

enthalten in: Thoracic cancer | 2024

von Kiritani, A. | Amino, Y. | Uchibori, K. | +9

10

Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer

enthalten in: Investigational new drugs | 2024

von Nogami, N. | Tokito, T. | Zenke, Y. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[41]